RxDoctor Payments Data

Jessica Stepp, DO

Family Medicine · Dallas, GANPI 1114210325

Payments from drug & device makers

$693in general payments, 2019–2025

Across 35 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$192
  • Lilly USA, LLC$153
  • Novo Nordisk$68
  • Takeda Pharmaceuticals U.S.A., Inc.$37
  • Exact Sciences$32
  • Sanofi-aventis U.S. LLC$32
  • plus $179 from 10 others

What the payments were for

  • Food & beverage$64894%
  • Education$456%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$693 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$46,459
Medicare patients
174
Services billed
1,109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate36$47,625
EliquisApixaban41$46,168
OzempicSemaglutide43$44,345
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$20,556
MounjaroTirzepatide20$20,510
XareltoRivaroxaban11$18,096
Repatha SureclickEvolocumab11$12,388
FarxigaDapagliflozin Propanediol11$11,037
Tresiba Flextouch U-100Insulin Degludec20$9,250
Breo ElliptaFluticasone/Vilanterol14$6,919
Advair HfaFluticasone Propion/Salmeterol13$4,698
Albuterol Sulfate HfaAlbuterol Sulfate121$4,147
Incruse ElliptaUmeclidinium Bromide12$4,124
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$3,786
Atorvastatin Calcium311$3,436

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$46,16841 claims
Novo NordiskOzempic$68$44,34543 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$16$31,59950 claims
Lilly USA, LLCMounjaro$153$20,51020 claims
AbbVieSynthroid$17$2,09730 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Dallas

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →